Esuprone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Esuprone
Esuprone.svg
Names
IUPAC name
3,4-Dimethyl-2-oxo-2H-chromen-7-yl ethanesulfonate
Identifiers
91406-11-0 N
ChEMBL ChEMBL18504 YesY
ChemSpider 59239 YesY
Jmol-3D images Image
PubChem 65827
UNII K7EB9E48ZE YesY
Properties[1]
C13H14O5S
Molar mass 282.31 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 N verify (what isYesY/N?)
Infobox references

Esuprone is an experimental drug candidate being investigated as an antidepressant.[2] It acts as an monoamine oxidase A (MAO-A) inhibitor.[3]

References[edit]

  1. ^ Ganellin, C. R (1996). Dictionary of pharmacological agents. CRC Press. p. 1056. ISBN 978-0-412-46630-4. 
  2. ^ Vértes, Attila (2003). Handbook of nuclear chemistry. Springer. p. 155. ISBN 978-1-4020-1316-4. 
  3. ^ Bergström, M; Westerberg, G; Németh, G; Traut, M; Gross, G; Greger, G; Müller-Peltzer, H; Safer, A et al. (1997). "MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography". European journal of clinical pharmacology 52 (2): 121–8. doi:10.1007/s002280050260. PMID 9174681.